Financial Performance - The company's operating revenue for Q1 2022 was ¥134,246,184.41, representing a decrease of 19.22% compared to the same period last year [6]. - The net profit attributable to shareholders was ¥16,093,060.08, down 59.45% year-on-year [6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥12,683,992.70, a decline of 66.64% compared to the previous year [6]. - Basic and diluted earnings per share were both ¥0.08, down 68.00% compared to the same period last year [9]. - The total comprehensive income attributable to the parent company for Q1 2022 was CNY 16,093,060.08, compared to CNY 39,689,926.57 in Q1 2021, representing a decrease of approximately 59.5% [37]. - Net profit for Q1 2022 was ¥14,993,326.89, compared to ¥38,375,405.93 in Q1 2021, reflecting a decline of approximately 60.9% [35]. Cash Flow - The net cash flow from operating activities was ¥1,447,560.62, reflecting a significant decrease of 89.88% year-on-year [9]. - Cash inflow from operating activities for Q1 2022 was CNY 144,960,960.65, a decrease of 22% from CNY 185,888,929.87 in Q1 2021 [40]. - Cash outflow from operating activities totaled CNY 143,513,400.03 in Q1 2022, down from CNY 171,582,269.97 in Q1 2021, reflecting a reduction of approximately 16.4% [40]. - Net cash flow from investing activities for Q1 2022 was -CNY 103,399,496.64, compared to a positive CNY 28,323,902.22 in Q1 2021, indicating a significant decline [40]. - Net cash flow from financing activities for Q1 2022 was CNY 64,509,412.91, a turnaround from -CNY 20,277,449.77 in Q1 2021 [42]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,157,126,665.12, an increase of 1.42% from the end of the previous year [9]. - The total current assets as of March 31, 2022, amounted to ¥1,034,676,358.46, a decrease of approximately 6.3% from ¥1,104,100,894.06 on December 31, 2021 [23]. - The company's total liabilities increased to ¥332,813,613.79 from ¥318,137,446.34, marking an increase of about 4.9% [27]. - The total non-current assets increased to ¥1,122,450,306.66 from ¥1,022,805,046.06, showing a growth of approximately 9.8% [26]. - Short-term borrowings rose significantly to ¥143,854,465.42 from ¥77,274,866.38, marking an increase of approximately 86% [26]. Research and Development - Research and development expenses totaled ¥13,086,316.81, a decrease of 11.33% year-on-year, while R&D expenses accounted for 9.75% of operating revenue, an increase of 0.87 percentage points [9]. - Research and development expenses for Q1 2022 were ¥12,588,533.16, down from ¥14,361,829.57 in Q1 2021, a decrease of about 12.4% [31]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,655 [17]. - Total equity attributable to shareholders rose to ¥1,828,027,053.70 from ¥1,811,382,762.95, an increase of approximately 0.9% [27]. Company Strategy - The company attributed the decline in net profit to decreased sales due to the pandemic and increased sales and management expenses [16]. - The company has not reported any significant new product developments or market expansions during this period [21]. - The company plans to continue focusing on market expansion and new product development to drive future growth [35].

Financial Performance - The company's operating revenue for Q3 2021 was ¥140,873,674.91, a decrease of 11.09% compared to the same period last year[8] - Net profit attributable to shareholders for Q3 2021 was ¥37,164,514.31, an increase of 4.67% year-over-year[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 30.80% to ¥18,359,658.26[8] - Total revenue for the first three quarters of 2021 reached ¥449,877,162.41, an increase of 20.1% compared to ¥374,726,793.63 in the same period of 2020[32] - Net profit for the first three quarters of 2021 was ¥84,825,337.97, compared to ¥78,888,059.93 in 2020, representing a year-on-year increase of 7.4%[39] - The total comprehensive income attributable to the parent company reached CNY 88,582,488.17, an increase from CNY 83,893,484.58 in the same period last year, reflecting a growth of approximately 8.1%[41] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,024,142,599.47, an increase of 45.04% compared to the end of the previous year[12] - The total assets increased to ¥2,024,142,599.47, up from ¥1,395,573,459.13, marking a growth of 45%[32] - The total liabilities of the company as of September 30, 2021, were not explicitly stated but are crucial for assessing financial health[27] - Non-current liabilities decreased to ¥26,809,096.01 from ¥47,338,215.16, a reduction of 43.4%[32] - The company reported a significant reduction in short-term borrowings, decreasing from ¥177,947,037.55 to ¥56,839,615.05, a drop of 68.1%[32] Shareholder Information - The number of shareholders at the end of the reporting period was 12,846, with the top ten shareholders holding a combined 39.88% of the shares[21] - The largest shareholder, Lianyungang Nuotai Investment Management Partnership, held 9.38% of the shares, totaling 20 million shares[21] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥131,827,280.03, an increase of 32.04% compared to the same period last year[12] - The net cash flow from operating activities was CNY 131,827,280.03, up from CNY 99,840,845.29, representing a year-over-year increase of about 32.1%[43] - Cash inflow from investment activities totaled CNY 638,790,339.17, significantly higher than CNY 49,997,237.92 in the previous year, indicating a substantial increase in investment recovery[43] - The net cash flow from financing activities was CNY 521,003,577.78, compared to CNY 40,676,922.91 in the same period last year, showing a remarkable increase[43] - The cash inflow from sales of goods and services was CNY 476,520,549.55, compared to CNY 376,279,416.67 in the previous year, marking an increase of about 26.6%[43] - The net increase in cash and cash equivalents for the period was CNY 450,175,389.71, a significant rise from CNY 14,840,289.98 in the same period last year[46] Research and Development - R&D expenses for Q3 2021 totaled ¥13,769,947.43, a decrease of 38.41% compared to the same period last year, representing 9.77% of operating revenue[12] - Research and development expenses for the first three quarters were ¥44,422,127.37, slightly up from ¥43,349,679.30, indicating a focus on innovation[35] Other Financial Metrics - Basic earnings per share for Q3 2021 were ¥0.18, a decrease of 18.18% year-over-year[12] - The weighted average return on equity for Q3 2021 was 2.11%, a decrease of 1.82 percentage points compared to the same period last year[12] - The company reported a basic and diluted earnings per share of CNY 0.48, down from CNY 0.52 in the previous year, reflecting a decrease of approximately 7.7%[41] Government Support and Market Strategy - The company received government subsidies amounting to ¥20,914,912.93 during the reporting period[12] - The company plans to expand its market presence and invest in new product development to drive future growth[32] Inventory and Receivables - Inventory levels rose to ¥236.94 million, up from ¥184.99 million, representing an increase of about 28% year-over-year[27] - The company's accounts receivable stood at ¥104.41 million, slightly decreasing from ¥107.42 million, showing a decline of around 2%[27] Currency Impact - The company experienced a foreign exchange loss of CNY 571,773.16, compared to a loss of CNY 3,975,556.23 in the previous year, indicating an improvement in currency impact[46] No Significant Changes - The company has not disclosed any new product developments or technological advancements during this reporting period[24] - There are no significant mergers or acquisitions reported in the current financial period[24]